Laparoscopic Anatomic vs. Nonanatomic Liver Resection for Large Hepatocellular Carcinoma (≥5 cm) in the Right Lobe

医学 肝细胞癌 切除缘 倾向得分匹配 外科 入射(几何) 切除术 肝切除术 波瓣 腹腔镜检查 内科学 病理 物理 光学
作者
ahmed badawy,Ho‐Seong Han,Tamer M. Elmahdy,Hossam Eldeen M. Soliman,Mohammad Hamdy Abo‐Ryia,Osama Helmy El-Khadrawy
出处
期刊:Hpb [Elsevier BV]
标识
DOI:10.1016/j.hpb.2024.01.005
摘要

Objective To determine the impacts and outcomes of laparoscopic anatomic liver resection (LAR) and laparoscopic nonanatomic resection (LNAR) in patients with large hepatocellular carcinoma (HCC) in the right lobe of the liver. Background There are few comparative studies of LAR and LNAR for large HCC. Method Three hundred thirty-seven patients underwent liver resection for large HCC (≥5 cm) at Seoul National University Bundang Hospital, Seoul, Korea, between January 2004 and December 2022. After the exclusion of patients treated with open hepatic resection and those who had left-lobe or bilobar tumors, 94 patients were ultimately included. Patients were divided into LAR group (61 patients) and LNAR group (33 patients). After propensity score matching (PSM) with 1:1 matching, 31 patients were included in each group. The outcomes in the two groups were compared. Results LAR group had longer operative time than LNAR group (333.7 ± 113.7 vs 210 ± 117.6 min, respectively, P < 0.001), wider safety margin (1.4 ± 1.5 vs 0.7 ± 0.7 cm, respectively, P = 0.015), and lower incidence of recurrence (25.8% vs. 54.8%, respectively, P = 0.021). Conclusion LAR required longer operative time, achieved wider safety margin, and had lower incidence of recurrence than LNAR. To determine the impacts and outcomes of laparoscopic anatomic liver resection (LAR) and laparoscopic nonanatomic resection (LNAR) in patients with large hepatocellular carcinoma (HCC) in the right lobe of the liver. There are few comparative studies of LAR and LNAR for large HCC. Three hundred thirty-seven patients underwent liver resection for large HCC (≥5 cm) at Seoul National University Bundang Hospital, Seoul, Korea, between January 2004 and December 2022. After the exclusion of patients treated with open hepatic resection and those who had left-lobe or bilobar tumors, 94 patients were ultimately included. Patients were divided into LAR group (61 patients) and LNAR group (33 patients). After propensity score matching (PSM) with 1:1 matching, 31 patients were included in each group. The outcomes in the two groups were compared. LAR group had longer operative time than LNAR group (333.7 ± 113.7 vs 210 ± 117.6 min, respectively, P < 0.001), wider safety margin (1.4 ± 1.5 vs 0.7 ± 0.7 cm, respectively, P = 0.015), and lower incidence of recurrence (25.8% vs. 54.8%, respectively, P = 0.021). LAR required longer operative time, achieved wider safety margin, and had lower incidence of recurrence than LNAR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
十字路口完成签到,获得积分10
3秒前
6秒前
彩虹猫完成签到 ,获得积分10
7秒前
maolingyu完成签到,获得积分10
12秒前
闪闪的向梦完成签到,获得积分10
12秒前
丹丹子完成签到 ,获得积分10
15秒前
cdercder应助复杂的溪流采纳,获得10
19秒前
希望天下0贩的0应助lilac采纳,获得10
20秒前
笑点低不言完成签到,获得积分10
22秒前
科研通AI5应助科研通管家采纳,获得10
23秒前
阿飘应助科研通管家采纳,获得10
23秒前
pluto应助科研通管家采纳,获得10
23秒前
CipherSage应助科研通管家采纳,获得10
23秒前
科研通AI5应助科研通管家采纳,获得10
24秒前
阿飘应助科研通管家采纳,获得10
24秒前
和谐诗双完成签到 ,获得积分10
24秒前
ding应助科研通管家采纳,获得10
24秒前
科研通AI5应助科研通管家采纳,获得10
24秒前
今后应助科研通管家采纳,获得10
24秒前
科研通AI5应助科研通管家采纳,获得30
24秒前
科研通AI2S应助科研通管家采纳,获得10
24秒前
24秒前
iNk应助科研通管家采纳,获得10
24秒前
24秒前
阿飘应助科研通管家采纳,获得10
24秒前
24秒前
ding应助科研通管家采纳,获得10
24秒前
25秒前
脑洞疼应助zrs采纳,获得10
25秒前
26秒前
田様应助雨前知了采纳,获得10
28秒前
FOREST完成签到,获得积分10
28秒前
吱吱熊sama完成签到,获得积分10
29秒前
Airy完成签到,获得积分10
31秒前
lilac发布了新的文献求助10
31秒前
合适怜南完成签到,获得积分10
31秒前
33秒前
33秒前
34秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 3000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
Fashion Brand Visual Design Strategy Based on Value Co-creation 350
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3777918
求助须知:如何正确求助?哪些是违规求助? 3323458
关于积分的说明 10214533
捐赠科研通 3038671
什么是DOI,文献DOI怎么找? 1667606
邀请新用户注册赠送积分活动 798207
科研通“疑难数据库(出版商)”最低求助积分说明 758315